Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.925 | 0.120 | 16 | 49830880 | intron variant | C/T | snv | 0.50 |
|
0.700 | 1.000 | 2 | 2018 | 2019 | ||||||||
|
16 | 49734135 | intron variant | C/A | snv | 0.64 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
0.925 | 0.120 | 16 | 49830880 | intron variant | C/T | snv | 0.50 |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.120 | 16 | 49830880 | intron variant | C/T | snv | 0.50 |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
16 | 49850619 | intron variant | C/A;G | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||||
|
16 | 49834602 | intron variant | C/A | snv | 0.40 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
16 | 49637266 | missense variant | T/C | snv | 3.1E-02 | 2.8E-02 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
16 | 49850016 | intron variant | T/A | snv | 0.16 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
1.000 | 0.120 | 16 | 49765545 | intron variant | CA/-;CACA;CACACA;CACACACA;CACACACACA | delins |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
16 | 49755426 | intron variant | A/C | snv | 0.74 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
16 | 49775652 | intron variant | A/G | snv | 0.73 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
16 | 49734010 | intron variant | C/T | snv | 0.61 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
16 | 49840765 | intron variant | A/G | snv | 0.24 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.925 | 0.040 | 16 | 49488523 | 3 prime UTR variant | G/C | snv | 7.4E-02 |
|
Musculoskeletal Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.925 | 0.040 | 16 | 49488523 | 3 prime UTR variant | G/C | snv | 7.4E-02 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
1.000 | 16 | 49636414 | missense variant | G/A;T | snv | 1.8E-04 |
|
0.700 | 0 | ||||||||||||
|
16 | 49635782 | stop gained | C/A;T | snv | 3.2E-05 |
|
0.700 | 0 | |||||||||||||
|
16 | 49730782 | missense variant | C/T | snv | 6.4E-05 | 2.8E-05 |
|
0.700 | 0 | ||||||||||||
|
0.925 | 0.120 | 16 | 49830880 | intron variant | C/T | snv | 0.50 |
|
Nutritional and Metabolic Diseases; Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.925 | 0.120 | 16 | 49830880 | intron variant | C/T | snv | 0.50 |
|
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.925 | 0.080 | 16 | 49797677 | intron variant | A/G | snv | 0.54 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.080 | 16 | 49797677 | intron variant | A/G | snv | 0.54 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 |